Sana Biotechnology (SANA) Other Non-Current Assets (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Other Non-Current Assets data on file, last reported at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (changed 0.0% YoY), and the FY2025 full-year result was $3.2 million, down 38.04% from the prior year.
• Other Non-Current Assets rose to $4.2 million in Q1 2026, from $3.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $10.5 million in Q2 2022 to a low of $3.2 million in Q4 2025.
• A 5-year average of $5.4 million and a median of $4.2 million in 2025 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets jumped 389.97% in 2022 and slumped 63.81% in 2023, its largest moves.
• Tracing SANA's Other Non-Current Assets over 5 years: stood at $10.5 million in 2022, then tumbled by 63.81% to $3.8 million in 2023, then surged by 34.76% to $5.1 million in 2024, then sank by 38.04% to $3.2 million in 2025, then soared by 32.37% to $4.2 million in 2026.
• Business Quant data shows SANA's Other Non-Current Assets at $4.2 million in Q1 2026, $3.2 million in Q4 2025, and $3.2 million in Q3 2025.